Rats with elevated genetic risk for metabolic syndrome exhibit cognitive deficiencies when young.

Physiol Behav

Centre for Interdisciplinary Brain Research, Department of Psychology, University of Jyväskylä, P.O. Box 35, FI-40014 University of Jyväskylä, Finland; Faculty of Sport and Health Sciences, University of Jyväskylä, P.O. Box 35, FI-40014 University of Jyväskylä, Finland.

Published: July 2021

Metabolic syndrome (MetS) is a known risk factor for cognitive decline. Using polygenic rat models selectively bred for high and low intrinsic exercise capacity and simultaneously modelling as low and high innate risk factor for MetS respectively, we have previously shown that adult animals with lower exercise capacity/higher MetS risk perform poorly in tasks requiring flexible cognition. However, it is not known whether these deficits in cognition are present already at young age. Also, it is unclear whether the high risk genome is related also to lower-level cognition, such as sensory gating measured as prepulse inhibition. In this study, young and adult (5-8 weeks and ~9 months) rats selectively bred for 36 generations as High-Capacity Runners (HCR) or Low-Capacity Runners (LCR) were tested for behavior in an open field task, modulation of startle reflex, and spatial learning in a T-maze. HCR rats were more active in the open field than LCR rats independent of age. Responses to the startle stimulus habituated to the same extent in LCR compared to HCR rats when young, but as adults, stronger habituation was seen in the HCR animals. The prepulse inhibition of startle response was equally strong in young HCR and LCR animals but the effect was shorter lasting in HCR animals. In T-maze, adult HCR animals unexpectedly showed attenuated learning, but we interpret this finding to stem from differences in motivation rather than learning ability. Overall, in the LCR rats with the risk genome for poor aerobic fitness and MetS, indications of compromised cognitive function are present already at a young age.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.physbeh.2021.113417DOI Listing

Publication Analysis

Top Keywords

hcr animals
12
metabolic syndrome
8
mets risk
8
risk factor
8
selectively bred
8
young age
8
risk genome
8
prepulse inhibition
8
open field
8
hcr rats
8

Similar Publications

A POCT assay based on commercial HCG strip for miRNA21 detection by integrating with RCA-HCR cascade amplification and CRISPR/Cas12a.

Mikrochim Acta

January 2025

Beijing Key Laboratory for Separation and Analysis in Biomedicine and Pharmaceuticals, School of Medical Technology, Beijing Institute of Technology, Beijing, 100081, China.

A point-of-care testing (POCT) assay based on commercial HCG strip was proposed for miRNA21 detection by integrating RCA-HCR cascaded isothermal amplification with CRISPR/Cas12a. Three modules were integrated in the proposed platform: target amplification module composed of rolling circle amplification (RCA) cascaded with hybridization chain reaction (HCR), signal transduction module composed of CRISPR/Cas12a combined with HCG-agarose gel beads probes, and signal readout module composed of commercial HCG strips. The proposed RCA-HCR-CRISPR/Cas12a-HCG strip assay for miRNA21 detection had high sensitivity, and the limit of detection was as low as 37 fM.

View Article and Find Full Text PDF

A fast hybridization chain reaction method in embryos and ovaries.

Fly (Austin)

December 2025

Degree Programs in Life and Earth Sciences, Graduate School of Science and Technology, University of Tsukuba, Tsukuba, Ibaraki, Japan.

The hybridization chain reaction (isHCR) is a powerful method for visualizing mRNA in many species. We present a rapid isHCR method for embryos and ovaries. Ethylene carbonate was added to the hybridization buffer to facilitate the hybridization reaction, and a modified short hairpin DNA was used in the amplification reaction; these modifications decreased the RNA staining time from 3 days to 1 day.

View Article and Find Full Text PDF

Redefining retinoic acid receptor expression in zebrafish embryos using Hybridization Chain Reaction.

Differentiation

December 2024

University of Louisville, School of Medicine, Department of Biochemistry and Molecular Genetics, 580 S Preston St, Louisville, KY, 40202, USA. Electronic address:

Retinoic Acid (RA) is the key signaling molecule during embryonic development with the RA pathway playing multiple roles in throughout development. Previous work has shown RA signaling to be key in development of the craniofacial skeleton. RA signaling is driven by RA binding to the nuclear transcription factors, retinoic acid receptor (RAR) and retinoic X receptor (RXR).

View Article and Find Full Text PDF

Whole-brain in situ mapping of neuronal activation in during social behaviors and optogenetic stimulation.

Elife

November 2024

Division of Biology and Biological Engineering, Tianqiao and Chrissy Chen Institute for Neuroscience, California Institute of Technology, Pasadena, United States.

Article Synopsis
  • - The study addresses the difficulty of monitoring neuronal activity in small, opaque organisms like fruit flies during social behaviors, which traditional methods fail to capture without interfering in their natural behaviors.
  • - Researchers use a new technique called HCR-3.0 to map brain-wide activity of aggression-related neurons during courtship and aggression, focusing on male-specific P1 interneurons.
  • - By leveraging HI-FISH and optogenetic methods, the team identifies and compares the activity of P1 neurons across different behaviors, providing insights into how these neurons respond differently during courtship versus aggression.
View Article and Find Full Text PDF

mRNA compartmentalization via multimodule DNA nanostructure assembly augments the immunogenicity and efficacy of cancer mRNA vaccine.

Sci Adv

November 2024

New Cornerstone Science Laboratory, CAS Key Laboratory of Biomedical Effects of Nanomaterials and Nanosafety and CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, 100190, China.

Article Synopsis
  • mRNA vaccines show promise for cancer treatment, but their effectiveness is currently limited by low immune response and inefficient mRNA expression.
  • A new approach uses a custom DNA nanostructure called MMDNS, which helps improve mRNA translation by concentrating mRNA and necessary reaction components in specific areas.
  • This innovative vaccine design results in a stronger immune response against tumors, helping to inhibit their growth and spread, making it a significant development in cancer immunotherapy.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!